Research Output per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 14 Similar Profiles
Multiple Myeloma
Medicine & Life Sciences
Plasma Cell Neoplasms
Medicine & Life Sciences
Bone Marrow
Medicine & Life Sciences
Flow Cytometry
Medicine & Life Sciences
Cell Transplantation
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Plasma Cells
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2000 2019
Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study
Lou, E., Vogel, R. I., Hoostal, S., Wong, P., Grad, A., Monu, M., Łukaszewski, T., Deshpande, J., Dickson, E. L., Klein, M. E., Linden, M. A., Subramanian, S., Teoh, D. G. & Geller, M. A., Jan 1 2019, In : Oncologist.Research output: Contribution to journal › Article
Circulating Neoplastic Cells
Platinum
MicroRNAs
Biomarkers
Prospective Studies
CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up
Gilles, S. R., Yohe, S. L., Linden, M. A., Dolan, M. M., Hirsch, B. A. & Grzywacz, B. J., Sep 9 2019, In : American journal of clinical pathology. 152, 4, p. 471-478 8 p.Research output: Contribution to journal › Article
T-Cell Prolymphocytic Leukemia
Mitogen Receptors
T-Lymphocyte Subsets
Natural Killer Cells
Flow Cytometry
Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease
Cayci, Z., Ozturk, K., Ustun, C., Omer, A. K., Dincer, E., Sachs, Z., Peterson, B. A. & Linden, M. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article
Fluorodeoxyglucose F18
Sarcoidosis
Lymphoma
2
Citations
(Scopus)
Sleeping beauty screen identifies RREB1 and other genetic drivers in human B-cell lymphoma
Rahrmann, E. P., Wolf, N. K., Otto, G. M., Heltemes Harris, L. M., Ramsey, L. B., Shu, J., LaRue, R. S., Linden, M. A., Rathe, S., Starr, T., Farrar, M. A., Moriarity, B. S. & Largaespada, D. A., Feb 1 2019, In : Molecular Cancer Research. 17, 2, p. 567-582 16 p.Research output: Contribution to journal › Article
Beauty
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Carrier Proteins
Follicular Lymphoma
Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients with Ovarian Cancer
Lou, E., Vogel, R. I., Hoostal, S., Klein, M. E., Linden, M. A., Teoh, D. G. & Geller, M. A., Aug 1 2019, In : JAMA Oncology. 5, 8, p. 1222-1224 3 p.Research output: Contribution to journal › Letter
Platinum
Ovarian Neoplasms
Biomarkers
Drug Therapy
Neoplasms